Paper · 2003
Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6.
PubMed, 30(7), 1630–1647 · Published 1 July 2003
In brief
“Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6.” is a 2003 paper by Peter A. Merkel and 5 co-authors, published in PubMed. OpenAlex counts 172 citations as of 22 November 2026, which puts it in the top 6% of works published in 2003 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 172
- Most cited in
- 2021 (11)
- Field-weighted impact
- 3.57
- References
- 163
- Authors
- 6
Abstract
Systemic sclerosis (SSc), also known as scleroderma, is a complex, multisystem disease that results in severe morbidity, disability, and life-threatening complications. The wide range of biological systems clinically involved, and the large spectrum of disease activity and damage that occurs in this disease have limited clinical investigation of SSc, especially therapeutic trials. The OMERACT 6… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Merkel, P. A., Clements, P. J., Reveille, J. D., Suarez-Almazor, M. E., Valentini, G., & Fürst, D. E. (2003). Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6. PubMed, 30(7), 1630–1647. https://pubmed.ncbi.nlm.nih.gov/12858472
MLA 9
Merkel, Peter A., et al. “Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6.” PubMed, vol. 30, no. 7, 2003, pp. 1630–1647. https://pubmed.ncbi.nlm.nih.gov/12858472.
Chicago
Merkel, Peter A., Philip J. Clements, John D. Reveille, Maria Eugenia Suarez-Almazor, Gabriele Valentini, and Daniel E. Fürst. 2003. “Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6.” PubMed 30 (7): 1630–1647. https://pubmed.ncbi.nlm.nih.gov/12858472.
Harvard
Merkel, P. A. et al. (2003) ‘Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6.’, PubMed, 30(7), pp. 1630–1647. Available at: https://pubmed.ncbi.nlm.nih.gov/12858472.
IEEE
P. A. Merkel, P. J. Clements, J. D. Reveille, M. E. Suarez-Almazor, G. Valentini, and D. E. Fürst, “Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6.,” PubMed, vol. 30, no. 7, pp. 1630–1647, 2003.
BibTeX
@article{merkel2003current,
title = {{Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6.}},
author = {Merkel, Peter A. and Clements, Philip J. and Reveille, John D. and Suarez-Almazor, Maria Eugenia and Valentini, Gabriele and Fürst, Daniel E.},
journal = {PubMed},
year = {2003},
volume = {30},
number = {7},
pages = {1630--1647},
url = {https://pubmed.ncbi.nlm.nih.gov/12858472}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 10 | |
| 2018 | 6 | |
| 2019 | 8 | |
| 2020 | 4 | |
| 2021 | 11 | |
| 2022 | 5 | |
| 2023 | 7 | |
| 2024 | 7 | |
| 2025 | 5 | |
| 2026 | 3 |
Its field-weighted citation impact is 3.57: it has been cited 3.57 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- systemic sclerosis
- outcome measures
- outcome measure validation
- skin involvement
- pulmonary involvement
- cardiac involvement
- Raynaud's phenomenon
- digital ulcers
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Merkel, P. A., Clements, P. J., Reveille, J. D., Suarez-Almazor, M. E., Valentini, G., & Fürst, D. E. (2003). Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6. PubMed, 30(7), 1630–1647. https://pubmed.ncbi.nlm.nih.gov/12858472
How many times has this paper been cited?
172 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Peter A. Merkel, Philip J. Clements, John D. Reveille, Maria Eugenia Suarez-Almazor, Gabriele Valentini, Daniel E. Fürst.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.